ciprofloxacin and cp-55,940

ciprofloxacin has been researched along with cp-55,940 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carvalho, P; Cutler, SJ; Dale, OR; Elokely, KM; ElSohly, MA; Galal Osman, A; Gul, W; Husni, AS; Khan, S; Klein, ML; Radwan, M; Ross, SA; Slade, D; Yadav, VK	1

Other Studies

1 other study(ies) available for ciprofloxacin and cp-55,940

Article	Year
Bioactive products from singlet oxygen photooxygenation of cannabinoids. European journal of medicinal chemistry, 2018, Jan-01, Volume: 143 Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen	2018

Article

Year

Bioactive products from singlet oxygen photooxygenation of cannabinoids.

European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen

2018